Related Experiment Videos

Neurochemical findings in Huntington's chorea

Essays in Neurochemistry and Neuropharmacology
|January 1, 1977
PubMed

Insights

Huntington's chorea involves brain cell loss, particularly in the caudate nucleus and putamen. Decreased GABA neurotransmitter levels may explain uncontrolled movements, suggesting GABA-mimetic drugs as a potential treatment.

Area of Science:

  • Neuroscience
  • Genetics
  • Biochemistry

Background:

  • Huntington's chorea is a dominant inherited neurological disorder causing involuntary movements.
  • Pathological examination shows atrophy in the caudate nucleus and putamen, with widespread cell loss, sparing the hippocampus.
  • Previous biochemical defect studies in chorea patients have yielded limited results.

Purpose of the Study:

  • To investigate the biochemical underpinnings of Huntington's chorea.
  • To explore neurotransmitter system abnormalities, specifically dopamine and GABA, in affected brains.
  • To identify potential therapeutic targets for Huntington's chorea.

Main Methods:

  • Analysis of post-mortem brain tissue from Huntington's chorea patients.
  • Measurement of neurotransmitter levels (dopamine, GABA) and enzyme activities (GAD, choline acetyltransferase).
  • Examination of cerebrospinal fluid (CSF) for dopamine metabolites (HVA).

Main Results:

  • Dopamine levels were normal or decreased; tyrosine hydroxylase activity was normal.
  • Significant reductions in GABA and its synthesizing enzyme GAD were observed in post-mortem choreic brains.
  • Decreased choline acetyltransferase activity was noted in some choreic brains.
  • GABA receptors were found to be intact.

Conclusions:

  • Reduced GABAergic neurotransmission offers a biochemical explanation for the motor symptoms of Huntington's chorea.
  • Intact GABA receptors suggest potential efficacy of GABA-mimetic drugs.
  • Further research is needed to identify the primary defect for early detection and potential eradication of the disorder.

Related Concept Videos